European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Retailers of Medical Goods by Country

In 2023, Germany led European healthcare expenditure on pharmaceuticals and medical non-durable goods at €68.86 billion, maintaining a lead with a 4.94% growth rate. France and Italy followed with €31.22 billion and €20.64 billion, each with slight growth and decline, respectively. Significant growth was noted in Romania (7.44%), Portugal (6.1%), and Cyprus (15.73%). The United Kingdom reported a steady expenditure with a minor increase of 0.41%. The Compound Annual Growth Rate over the last five years indicates moderate, consistent growth among most European nations, with notable increases in smaller economies like Malta (10.64%).

Looking forward, several trends are expected to shape the market, including the impact of digital healthcare transformation, pandemic recovery efforts, and demographic shifts leading to increased medical expenditure. Health innovation and pricing reforms will also play pivotal roles in expenditure patterns across Europe.